MetaCap

MiniMed Group Cash Flow Statement

NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD

19.71-0.09 (-0.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

MiniMed Group free cash flow

In fiscal 2026, MiniMed Group generated -$197.0 million of operating cash flow and spent $223.0 million on capital expenditures. That left free cash flow of -$420.0 million, a free-cash-flow margin of -13.5% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

MiniMed Group cash flow statement (annual)

MiniMed Group annual cash flow statement
Fiscal year (USD)FY 20262026-04-24FY 20252025-04-25FY 20242024-04-26
Net Income-317.00M-198.00M-107.00M
Net Income growth (YoY)———
Depreciation & Amortization156.00M143.00M129.00M
Stock-Based Compensation46.00M41.00M38.00M
Change in Working Capital-29.00M-19.00M5.00M
Operating Cash Flow-197.00M140.00M41.00M
Capital Expenditures-223.00M-193.00M-148.00M
Investing Cash Flow-233.00M-193.00M-157.00M
Financing Cash Flow716.00M10.00M112.00M
Net Change in Cash287.00M-43.00M-4.00M
Free Cash Flow-420.00M-53.00M-107.00M

This table shows 3 annual periods of MiniMed Group's cash flow statement, from FY 2026 back to FY 2024, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MMED's reporting calendar. What is a cash flow statement?

More financial data